These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26108575)

  • 1. Viewpoint: It is time to reconsider policy for population-based mammography screening.
    Kearney AJ
    J Public Health Policy; 2015 Aug; 36(3):259-69. PubMed ID: 26108575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
    Bell RJ
    Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
    Ringash J;
    CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of screening mammography in organized programs in Canada in 1996. The Database Management Subcommittee to the National Committee for the Canadian Breast Cancer Screening Initiative.
    Paquette D; Snider J; Bouchard F; Olivotto I; Bryant H; Decker K; Doyle G
    CMAJ; 2000 Oct; 163(9):1133-8. PubMed ID: 11079057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and harms of mammography screening.
    Løberg M; Lousdal ML; Bretthauer M; Kalager M
    Breast Cancer Res; 2015 May; 17(1):63. PubMed ID: 25928287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening mammography in women less than age 50 years.
    Kerlikowske K
    Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in mammography utilization, 1981 to 1994.
    Gaudette LA; Altmayer CA; Nobrega KM; Lee J
    Health Rep; 1996; 8(3):17-27(Eng); 19-30(Fre). PubMed ID: 9085118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on the Canadian National Breast Screening study.
    Van Zee KJ; Hansen NM; Barrio AV; Connor CS; Danforth DN; Euhus DM; Kulkarni SA; McCready DR; McLaughlin S; Wilke LG
    Ann Surg Oncol; 2014 Dec; 21(13):4397-8. PubMed ID: 24859935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Why reconsider the recommendation of breast cancer screening?].
    Tesser CD; d'Ávila TL
    Cad Saude Publica; 2016 May; 32(5):. PubMed ID: 27253456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. United States Preventive Services Task Force screening mammography recommendations: science ignored.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.
    Paci E; Broeders M; Hofvind S; Puliti D; Duffy SW;
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1159-63. PubMed ID: 24991022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harms of screening mammography for breast cancer in Japanese women.
    Kasahara Y; Kawai M; Tsuji I; Tohno E; Yokoe T; Irahara M; Tangoku A; Ohuchi N
    Breast Cancer; 2013 Oct; 20(4):310-5. PubMed ID: 22282164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
    US Preventive Services Task Force
    Ann Intern Med; 2009 Nov; 151(10):716-26, W-236. PubMed ID: 19920272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.